338 related articles for article (PubMed ID: 10423899)
1. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
Okuma M; Iikura Y
Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
Kotake T; Mihara M; Shibakawa M; Asamoto
Arerugi; 1997 Apr; 46(4):370-5. PubMed ID: 9154697
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
Kotake T; Mihara M; Shibakawa M; Asamoto H
Nihon Rinsho; 1996 Nov; 54(11):3119-24. PubMed ID: 8950965
[TBL] [Abstract][Full Text] [Related]
4. [A comparative study of the pharmacokinetics and urinary metabolites of sustained-release theophylline syrup, granule and tablet preparations].
Horiuchi Y; Takemura T; Ueno K
Arerugi; 1991 Sep; 40(9):1186-93. PubMed ID: 1958133
[TBL] [Abstract][Full Text] [Related]
5. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
6. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
Kelly HW; Murphy S
Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
8. [Serum concentrations of the pyridoxal and pyridoxal-5'-phosphate in children during sustained-release theophylline therapy].
Tanaka I; Ito Y; Hiraga Y; Fujino M; Kobayashi K
Arerugi; 1996 Oct; 45(10):1098-105. PubMed ID: 8958656
[TBL] [Abstract][Full Text] [Related]
9. Apparent decrease in population clearance of theophylline: implications for dosage.
Asmus MJ; Weinberger MM; Milavetz G; Marshik P; Teresi ME; Hendeles L
Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
Iwasaki E; Baba M
Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
[TBL] [Abstract][Full Text] [Related]
11. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
Logvinoff MM; Weinstein DB; Watts MT; Seifert B
Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
13. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
van der Vet AP; Drost RH; Kreukniet J; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
16. [Slow-release theophylline for the treatment of asthmatic children].
Iwasaki E; Baba M
Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
18. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
20. [Sustained-release theophylline: study in a child population].
Díaz Fernández M; Gracía Hidalgo A; Mateo Cañas G; López Elorze F
An Esp Pediatr; 1986 Jan; 24(1):7-13. PubMed ID: 3963648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
